Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
ENZON PHARM Add to My Watchlist (NSDQ: ENZN) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Enzon 9.04 +0.04 (+0.44%) 810,074
685 Route 202/206
Bridgewater, NJ 08807 US
(908) 541-8600
(908) 575-9457 fax
www.enzon.com
CEO Jeffrey H. Buchalter
Auditor KPMG LLP
Exchange Traded NQ
ISIN Number US2939041081
CIK Number 727510
NAICS Code 325414
Business Summary
A biopharmaceutical company, which is dedicated to developing, manufacturing and commercializing important medicines for patients with cancer and other life-threatening conditions.
Number of Employees 351
Share Fundamentals
Market Cap 410.92M
Shares Outstanding 45.46M
Float 44.18M
Short Interest 12.40M
Financial Strength
Revenue (TTM) $188,844,000
Earnings (TTM) $781,000
Quick Ratio 4.2:1
Current Ratio 5.1:1
Total Debt/Equity 4.68:1
Profitability
Gross Margin 83.4%
EBITDA Margin 12.1%
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs